tradingkey.logo
tradingkey.logo
Search

Psyence Biomedical Ltd

PBM
Add to Watchlist
3.190USD
-0.170-5.06%
Close 07-31 16:00ETQuotes delayed by 15 min
36.38KMarket Cap
LossP/E TTM

Psyence Biomedical Ltd

3.190
-0.170-5.06%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-5.06%

5 Days

+8.14%

1 Month

+2.57%

6 Months

+397.97%

Year to Date

+323.41%

1 Year

-36.58%

Key Figures
3.210Open
3.240High
70.55KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
618.70%Turnover Ratio
3.360Prev. Close
3.050Low
156.47KTurnover
0.04P/E Static
0.01P/B
0.00%Div Yield TTM
--ROA
74.93852wk High
0.60Volume Ratio
1.01MNet Profit
11.40KShares
-389.9158EPS TTM
1.69Beta
--ROE
1.92052wk Low
5.65%Amplitude
--Gross Margin
36.38KMarket Cap
1.00Reward/Risk
10.58%Risk Rate

Psyence Biomedical Ltd News

More news coming soon, stay tuned...

Indicators

Indicators
Sell(3)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.128
Neutral
RSI(14)
50.797
Neutral
STOCH(KDJ)(9,3,3)
51.319
Neutral
ATR(14)
0.262
High Vlolatility
CCI(14)
72.730
Neutral
Williams %R
56.436
Sell
TRIX(12,20)
-0.192
Sell
StochRSI(14)
49.989
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
3.142
Buy
MA10
3.070
Buy
MA20
3.018
Buy
MA50
3.313
Sell
MA100
3.880
Sell
MA200
2.979
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Psyence Biomedical Ltd Info

Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Ticker SymbolPBM
CompanyPsyence Biomedical Ltd
CEOMaresky (Neil)
Website

Shareholders

Shareholders
Shareholders
Proportion
Parallel Advisors, LLC
6.59%
Weiner (Jeffrey David)
2.26%
KAOS Capital Ltd
2.19%
Virtu Americas LLC
0.26%
White Lion Capital LLC
0.09%
Other
88.62%

FAQs

What is the current price of Psyence Biomedical Ltd (PBM)?

The current price of Psyence Biomedical Ltd (PBM) is 3.19.

What is the symbol of Psyence Biomedical Ltd?

The ticker symbol of Psyence Biomedical Ltd is PBM.

What is the 52-week high of Psyence Biomedical Ltd?

The 52-week high of Psyence Biomedical Ltd is 74.94.

What is the 52-week low of Psyence Biomedical Ltd?

The 52-week low of Psyence Biomedical Ltd is 1.92.

What is the market capitalization of Psyence Biomedical Ltd?

The market capitalization of Psyence Biomedical Ltd is 36.38K.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.